An AllTrials project

NCT06662162: An ongoing trial by i-Lumen Scientific AUS PTY LTD

This trial is ongoing. It must report results 2 years, 3 months from now.

Full data

Full entry on ClinicalTrials.gov NCT06662162
Title Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration (i-SIGHT2): a Multicentre, Randomised, Sham-controlled, Double-masked, Clinical Device Trial.
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date May 7, 2025
Completion date March 31, 2027
Required reporting date March 30, 2028, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Dec. 12, 2025
Days late None